Trial intelligence / Profile preview

Benzbromarone for left ventricular diastolic function in hypertensive adults with left ventricular hypertrophy and asymptomatic hyperuricemia

ChiCTR1900023033Phase 4Recruiting

Sponsor
Shanghai Ninth People's Hospital
Start
Jan 2019
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, open-label trial of benzbromarone in hyperuricemia (2 arms), sponsored by Shanghai Ninth People's Hospital. Primary endpoint: Left ventricular diastolic function. Started Jan 2019; status: recruiting.

02

Drugs

benzbromarone
03

Conditions

hyperuricemia

Beyond the preview

Go deeper on ChiCTR1900023033.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR1900023033.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call